Cargando…
Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer
OBJECTIVE: To prospectively compare the interobserver variability of combined transrectal ultrasound (TRUS)/computed tomography (CT)- vs. CT only- vs. magnetic resonance imaging (MRI) only-based contouring of the high-risk clinical target volume (CTV(HR)) in image-guided adaptive brachytherapy (IGAB...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653783/ https://www.ncbi.nlm.nih.gov/pubmed/32621011 http://dx.doi.org/10.1007/s00066-020-01656-2 |
_version_ | 1783607944285257728 |
---|---|
author | Smet, Stéphanie Nesvacil, Nicole Knoth, Johannes Sturdza, Alina Najjari-Jamal, Dina Jelinek, Filip Kronreif, Gernot Pötter, Richard Widder, Joachim Kirisits, Christian Schmid, Maximilian P. |
author_facet | Smet, Stéphanie Nesvacil, Nicole Knoth, Johannes Sturdza, Alina Najjari-Jamal, Dina Jelinek, Filip Kronreif, Gernot Pötter, Richard Widder, Joachim Kirisits, Christian Schmid, Maximilian P. |
author_sort | Smet, Stéphanie |
collection | PubMed |
description | OBJECTIVE: To prospectively compare the interobserver variability of combined transrectal ultrasound (TRUS)/computed tomography (CT)- vs. CT only- vs. magnetic resonance imaging (MRI) only-based contouring of the high-risk clinical target volume (CTV(HR)) in image-guided adaptive brachytherapy (IGABT) for locally advanced cervical cancer (LACC). METHODS: Five patients with LACC (FIGO stages IIb–IVa) treated with radiochemotherapy and IGABT were included. CT, TRUS, and T2-weighted MRI images were performed after brachytherapy applicator insertion. 3D-TRUS image acquisition was performed with a customized ultrasound stepper device and software. Automatic applicator reconstruction using optical tracking was performed in the TRUS dataset and TRUS and CT images were fused with rigid image registration with the applicator as reference structure. The CTV(HR) (based on the GEC-ESTRO recommendations) was contoured by five investigators on the three modalities (CTV(HR)_CT, CTV(HR)_TRUS-CT, and CTV(HR)_MRI). A consensus reference CTV(HR)_MRI (MRIref) was defined for each patient. Descriptive statistics and overlap measures were calculated using RTslicer (SlicerRT Community and Percutaneous Surgery Laboratory, Queen’s University, Canada), comparing contours of every observer with one another and with the MRIref. RESULTS: The interobserver coefficient of variation was 0.18 ± 0.05 for CT, 0.10 ± 0.04 for TRUS-CT, and 0.07 ± 0.03 for MRI. Interobserver concordance in relation to the MRIref expressed by the generalized conformity index was 0.75 ± 0.04 for MRI, 0.51 ± 0.10 for TRUS-CT, and 0.48 ± 0.06 for CT. The mean CTV(HR)_CT volume of all observers was 71% larger than the MRIref volume, whereas the mean CTV(HR)_TRUS-CT volume was 15% larger. CONCLUSION: Hybrid TRUS-CT as an imaging modality for contouring the CTV(HR) in IGABT for LACC is feasible and reproducible among multiple observers. TRUS-CT substantially reduces overestimation of the CTV(HR) volume of CT alone while maintaining similar interobserver variability. |
format | Online Article Text |
id | pubmed-7653783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-76537832020-11-12 Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer Smet, Stéphanie Nesvacil, Nicole Knoth, Johannes Sturdza, Alina Najjari-Jamal, Dina Jelinek, Filip Kronreif, Gernot Pötter, Richard Widder, Joachim Kirisits, Christian Schmid, Maximilian P. Strahlenther Onkol Original Article OBJECTIVE: To prospectively compare the interobserver variability of combined transrectal ultrasound (TRUS)/computed tomography (CT)- vs. CT only- vs. magnetic resonance imaging (MRI) only-based contouring of the high-risk clinical target volume (CTV(HR)) in image-guided adaptive brachytherapy (IGABT) for locally advanced cervical cancer (LACC). METHODS: Five patients with LACC (FIGO stages IIb–IVa) treated with radiochemotherapy and IGABT were included. CT, TRUS, and T2-weighted MRI images were performed after brachytherapy applicator insertion. 3D-TRUS image acquisition was performed with a customized ultrasound stepper device and software. Automatic applicator reconstruction using optical tracking was performed in the TRUS dataset and TRUS and CT images were fused with rigid image registration with the applicator as reference structure. The CTV(HR) (based on the GEC-ESTRO recommendations) was contoured by five investigators on the three modalities (CTV(HR)_CT, CTV(HR)_TRUS-CT, and CTV(HR)_MRI). A consensus reference CTV(HR)_MRI (MRIref) was defined for each patient. Descriptive statistics and overlap measures were calculated using RTslicer (SlicerRT Community and Percutaneous Surgery Laboratory, Queen’s University, Canada), comparing contours of every observer with one another and with the MRIref. RESULTS: The interobserver coefficient of variation was 0.18 ± 0.05 for CT, 0.10 ± 0.04 for TRUS-CT, and 0.07 ± 0.03 for MRI. Interobserver concordance in relation to the MRIref expressed by the generalized conformity index was 0.75 ± 0.04 for MRI, 0.51 ± 0.10 for TRUS-CT, and 0.48 ± 0.06 for CT. The mean CTV(HR)_CT volume of all observers was 71% larger than the MRIref volume, whereas the mean CTV(HR)_TRUS-CT volume was 15% larger. CONCLUSION: Hybrid TRUS-CT as an imaging modality for contouring the CTV(HR) in IGABT for LACC is feasible and reproducible among multiple observers. TRUS-CT substantially reduces overestimation of the CTV(HR) volume of CT alone while maintaining similar interobserver variability. Springer Berlin Heidelberg 2020-07-03 2020 /pmc/articles/PMC7653783/ /pubmed/32621011 http://dx.doi.org/10.1007/s00066-020-01656-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Smet, Stéphanie Nesvacil, Nicole Knoth, Johannes Sturdza, Alina Najjari-Jamal, Dina Jelinek, Filip Kronreif, Gernot Pötter, Richard Widder, Joachim Kirisits, Christian Schmid, Maximilian P. Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer |
title | Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer |
title_full | Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer |
title_fullStr | Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer |
title_full_unstemmed | Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer |
title_short | Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer |
title_sort | hybrid trus/ct with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653783/ https://www.ncbi.nlm.nih.gov/pubmed/32621011 http://dx.doi.org/10.1007/s00066-020-01656-2 |
work_keys_str_mv | AT smetstephanie hybridtrusctwithopticaltrackingfortargetdelineationinimageguidedadaptivebrachytherapyforcervicalcancer AT nesvacilnicole hybridtrusctwithopticaltrackingfortargetdelineationinimageguidedadaptivebrachytherapyforcervicalcancer AT knothjohannes hybridtrusctwithopticaltrackingfortargetdelineationinimageguidedadaptivebrachytherapyforcervicalcancer AT sturdzaalina hybridtrusctwithopticaltrackingfortargetdelineationinimageguidedadaptivebrachytherapyforcervicalcancer AT najjarijamaldina hybridtrusctwithopticaltrackingfortargetdelineationinimageguidedadaptivebrachytherapyforcervicalcancer AT jelinekfilip hybridtrusctwithopticaltrackingfortargetdelineationinimageguidedadaptivebrachytherapyforcervicalcancer AT kronreifgernot hybridtrusctwithopticaltrackingfortargetdelineationinimageguidedadaptivebrachytherapyforcervicalcancer AT potterrichard hybridtrusctwithopticaltrackingfortargetdelineationinimageguidedadaptivebrachytherapyforcervicalcancer AT widderjoachim hybridtrusctwithopticaltrackingfortargetdelineationinimageguidedadaptivebrachytherapyforcervicalcancer AT kirisitschristian hybridtrusctwithopticaltrackingfortargetdelineationinimageguidedadaptivebrachytherapyforcervicalcancer AT schmidmaximilianp hybridtrusctwithopticaltrackingfortargetdelineationinimageguidedadaptivebrachytherapyforcervicalcancer |